Australia markets closed

Cardiff Oncology, Inc. (XE7C.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.1200-0.0600 (-1.89%)
As of 08:23AM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts4444
Avg. Estimate-0.17-0.18-0.66-0.92
Low estimate-0.19-0.2-0.71-1.15
High estimate-0.15-0.16-0.62-0.68
Year ago EPS-0.19-0.19-1.08-0.66
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts4444
Avg. Estimate30k30k200k150k
Low estimateN/AN/A140kN/A
High estimate70k70k280k400k
Year ago sales136k119k366k200k
Sales growth (year/est)-77.90%-74.80%-45.40%-25.00%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.19-0.14-0.15-0.15
Actual EPS-0.19-0.19-0.14-0.17
Difference0-0.050.01-0.02
Surprise %0.00%-35.70%6.70%-13.30%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.17-0.18-0.66-0.92
7 days ago-0.17-0.18-0.66-0.92
30 days ago-0.17-0.18-0.66-0.92
60 days ago-0.17-0.18-0.64-1.01
90 days ago-0.17-0.18-0.64-1.01
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesXE7C.FIndustrySector(s)S&P 500
Current qtr.10.50%N/AN/AN/A
Next qtr.5.30%N/AN/AN/A
Current year38.90%N/AN/AN/A
Next year-39.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A